Oncolytic Herpes Simplex Virus Decreased Rhabdomyosarcoma Cell Survival In Vitro and In Vivo

被引：0
|
作者：
Waters, Alicia M. [1 ]
Stewart, Jerry [1 ]
Friedman, Gregory K. [1 ]
Gillespie, G. Y. [1 ]
Markert, James M. [1 ]
Beierle, Elizabeth A. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2015年 / 221卷 / 04期
关键词：
D O I：
10.1016/j.jamcollsurg.2015.07.244
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S105 / S106
页数：2
相关论文
共 50 条
  • [1] Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
    Ghose, Jayeeta
    Dona, Ada
    Murtadha, Mariam
    Gunes, Emine Gulsen
    Caserta, Enrico
    Yoo, Ji Young
    Russell, Luke
    Jaime-Ramirez, Alena Cristina
    Barwick, Benjamin G.
    Gupta, Vikas A.
    Sanchez, James F.
    Sborov, Douglas W.
    Rosen, Steven T.
    Krishnan, Amrita
    Boise, Lawrence H.
    Kaur, Balveen
    Hofmeister, Craig C.
    Pichiorri, Flavia
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 20 : 519 - 531
  • [2] Oncolytic herpes simplex virus and temozolomide synergistically inhibit breast cancer cell tumorigenesis in vitro and in vivo
    Fan, Jingjing
    Jiang, Hua
    Cheng, Lin
    Ma, Binlin
    Liu, Renbin
    ONCOLOGY LETTERS, 2021, 21 (02)
  • [3] Effect of oncolytic herpes simplex virus on fusion-positive rhabdomyosarcoma to radiotherapy.
    Shaikh, Maryam G.
    Nazam, Nazia
    Butey, Swatika
    Erwin, Michael H.
    Stewart, Jerry E.
    Aye, Jamie
    Beierle, Elizabeth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma
    Waters, Alicia M.
    Stafman, Laura L.
    Garner, Evan F.
    Mruthyunjayappa, Smitha
    Stewart, Jerry E.
    Friedman, Gregory K.
    Coleman, Jennifer M.
    Markert, James M.
    Gillespie, G. Yancey
    Beierle, Elizabeth A.
    TRANSLATIONAL ONCOLOGY, 2016, 9 (05): : 419 - 430
  • [5] Oncolytic herpes simplex virus and immunotherapy
    Wenqing Ma
    Hongbin He
    Hongmei Wang
    BMC Immunology, 19
  • [6] Oncolytic herpes simplex virus and immunotherapy
    Ma, Wenqing
    He, Hongbin
    Wang, Hongmei
    BMC IMMUNOLOGY, 2018, 19
  • [7] Nectin-1 determines the susceptibility of malignant melanoma to oncolytic herpes simplex virus in vitro and in vivo
    Schwertner, B.
    Lindner, G.
    Stauner, C. Toledo
    Klapproth, E.
    Magnus, C.
    Rohrhofer, A.
    Gross, S.
    Schuler-Thurner, B.
    Oettl, V.
    Feichtgruber, N.
    Drexler, K.
    Evert, K.
    Krahn, M.
    Berneburg, M.
    Schmidt, B.
    Schuster, P.
    Haferkamp, S.
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (02) : E25 - E25
  • [8] Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo
    Yin, Lei
    Zhao, Chunhong
    Han, Jixia
    Li, Zengjun
    Zhen, Yanan
    Xiao, Ruixue
    Xu, Zhongfa
    Sun, Yanlai
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 117 - 130
  • [9] Nectin-1 Expression Correlates with the Susceptibility of Malignant Melanoma to Oncolytic Herpes Simplex Virus In Vitro and In Vivo
    Schwertner, Barbara
    Lindner, Georg
    Stauner, Camila Toledo
    Klapproth, Elisa
    Magnus, Clara
    Rohrhofer, Anette
    Gross, Stefanie
    Schuler-Thurner, Beatrice
    Oettl, Veronika
    Feichtgruber, Nicole
    Drexler, Konstantin
    Evert, Katja
    Krahn, Michael P.
    Berneburg, Mark
    Schmidt, Barbara
    Schuster, Philipp
    Haferkamp, Sebastian
    CANCERS, 2021, 13 (12)
  • [10] Oncolytic herpes simplex virus for tumor therapy
    Hu, JCC
    Coffin, RS
    VIRAL VECTORS FOR TREATING DISEASES OF THE NERVOUS SYSTEM, 2003, 55 : 165 - 184
12345